China’s Humanoid Robot “Seven Little Dragons” Confront Diverging Strategies and Challenges

China’s humanoid robotics industry has entered a phase of intense capital inflows and heightened expectations. Unitree Robotics’ IPO application has been accepted, Galaxy General set a financing record with RMB 2.5 billion in a single round, Qianxun Intelligent surpassed RMB 10 billion valuation within two years, and Xinghaitu secured RMB 2 billion in its B+ round. Data show that in Q1 2026, financing in embodied intelligence reached RMB 20–30 billion, far exceeding the same period in 2025. April continued the momentum, with Zhongqing Robotics, Digua Robotics, Qianxun Intelligent, and Xingdong Jiyuan all announcing billion‑level financings, making robotics the second‑largest track by financing volume.

Seven companies — Unitree Robotics, Zhiyuan Robotics, Leju Robotics, Zhongqing Robotics, Galaxy General, Songyan Power, and Accelerated Evolution — have been dubbed the “Seven Little Dragons of Humanoid Robots.” Each has raised intensively, with valuations above RMB 10 billion, backed by Sequoia, Hillhouse, Meituan, CATL, and BYD. Yet behind the shared label, their strategies diverge sharply. Some rely on shipment volume to establish first‑mover advantage, others bet on technical breakthroughs, some polish hardware, and others aim to build general AI brains.

Valuations reveal stark differences. Galaxy General leads at RMB 20 billion (USD 3 billion), despite not achieving scaled shipments, focusing instead on humanoid robot brains. Unitree, Zhiyuan, and Leju are valued RMB 12–15 billion, with shipment advantages. Unitree shipped 5,500 units in 2025, generating RMB 1.708 billion revenue, up 335% year‑on‑year, with 60% gross margin. Its cost control allowed pricing at RMB 99,000, far below competitors at RMB 700,000–800,000. Zhiyuan shipped 5,100 units in 2025 and surpassed 10,000 cumulative units by March 2026, emphasizing sustainable customer demand over volume competition. It secured RMB 78 million in orders from China Mobile and advanced in industrial scenarios. Leju, the most established, has completed IPO counseling and leverages engineering and supply chain strengths, with its Kuafu series achieving over 90% domestic component rates. Zhongqing, with its T800 priced from RMB 180,000 and PM01 from RMB 88,000, has RMB 500 million in framework orders and plans 4,000–5,000 units in 2026, scaling to 30,000–50,000 units by 2027–2028. Accelerated Evolution focuses on “small humanoid” robots for developers, competitions, and education, offering open hardware and tools. Songyan Power specializes in bionic robots, debuting five robots at the 2026 Spring Festival Gala with actress Cai Ming, showcasing realistic facial expressions powered by 32 motors and proprietary Audio‑to‑Face algorithms.

Despite capital inflows, challenges remain. Technical limits are evident: humanoid robots still struggle in unstructured factory environments, with simulation‑to‑real performance dropping about 40% and real success rates below 30%. Commercialization paths are unclear, with ROI timelines stretching three to five years. Even with robots entering factories, integration is costly and slow, requiring adjustments to production lines and significant investment.

Among the seven, Unitree and Zhiyuan are best positioned. Unitree is the only profitable firm, turning losses into RMB 600 million net profit in 2025, supported by strong cash flow. Zhiyuan ranks high in shipments and has secured industrial orders, making its commercialization path clearer. Zhongqing and Accelerated Evolution face critical scaling tests, with Zhongqing preparing thousands of units for delivery and Accelerated Evolution needing to prove that “small humanoid” robots have sufficient market space. Galaxy General, Leju, and Songyan Power confront tougher challenges: Galaxy General’s high valuation rests on technical vision, risking a bubble if commercialization lags; Leju must transition from education to industrial applications; Songyan Power is entering the consumer market with its Bumi robot, but the sector remains immature and faces intensifying cost competition.

Global competition adds pressure. Tesla is repurposing its FSD technology for humanoid robots, while U.S. unicorn Figure develops the Helix foundation model. Overseas financing averages RMB 1.312 billion per round, nearly eight times China’s RMB 165 million. Chinese firms lead in shipments, reflecting rapid innovation and willingness to scale, but industry insiders expect 2026 to be a decisive watershed, with true large‑scale commercialization only beginning after 2029. By year‑end, the roster of “Seven Little Dragons” may already change.